US Patent Issued to 10x Genomics on May 13 for "Engineered reverse transcriptase enzymes with enhanced enzymatic activity in nanoliter reaction" (California Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,463, issued on May 13, was assigned to 10x Genomics Inc. (Pleasanton, Calif.).

"Engineered reverse transcriptase enzymes with enhanced enzymatic activity in nanoliter reaction" was invented by Sonya A. Clark (Pleasanton, Calif.), Derek Hunter Vallejo (Pleasanton, Calif.), Carolina Cuellar (Pleasanton, Calif.) and Katherine Pfeiffer (Pleasanton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The application provides compositions including engineered reverse transcriptases with at least one altered reverse-transcriptase related activity. The engineered reverse transcriptases or reverse transcription enzymes unexpectedly exhibit one or more alte...